Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%)
< Home < Back

Dr. Reddy's Lab - Quaterly Results

Date: 28-07-2022
A fair growth of 5.74% in the revenue at Rs. 36306.00 millions was reported in the June 2022 quarter as compared to Rs. 34335.00 millions during year-ago period.A humble growth in net profit of 20.83% reported in the quarter ended June 2022 to Rs. 4995.00  millions from Rs. 4134.00 millions.OP of the company witnessed a marginal growth to 9829.00 millions from 7481.00 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 36306.00 34335.00 5.74 36306.00 34335.00 5.74 144052.00 133491.00 7.91
Other Income 4034.00 1862.00 116.65 4034.00 1862.00 116.65 4820.00 8011.00 -39.83
PBIDT 9829.00 7481.00 31.39 9829.00 7481.00 31.39 30761.00 39379.00 -21.88
Interest 98.00 65.00 50.77 98.00 65.00 50.77 380.00 467.00 -18.63
PBDT 9731.00 7416.00 31.22 9731.00 7416.00 31.22 30381.00 38912.00 -21.92
Depreciation 2215.00 1971.00 12.38 2215.00 1971.00 12.38 8143.00 8350.00 -2.48
PBT 7516.00 5445.00 38.03 7516.00 5445.00 38.03 22238.00 30562.00 -27.24
TAX 2521.00 1311.00 92.30 2521.00 1311.00 92.30 6006.00 8698.00 -30.95
Deferred Tax 1163.00 327.00 255.66 1163.00 327.00 255.66 2080.00 3297.00 -36.91
PAT 4995.00 4134.00 20.83 4995.00 4134.00 20.83 16232.00 21864.00 -25.76
Equity 832.00 832.00 0.00 832.00 832.00 0.00 832.00 832.00 0.00
PBIDTM(%) 27.07 21.79 24.25 27.07 21.79 24.25 21.35 29.50 -27.61